India's Surge to Global Homoeopathy Leadership

India is emerging as a global leader in homoeopathy, surpassing Germany in quality and standards. With AYUSH Premium Mark and NABL accreditation, India is closing the gap in global markets. Experts predict significant growth in exports due to India's clinical and regulatory advancements.

India is set to emerge as a global leader in the homoeopathy sector, overtaking Germany in terms of quality and global standards. This shift is fueled by strong clinical expertise, a vast network of practitioners, and internationally recognised certifications like the AYUSH Premium Mark and NABL accreditation.

India boasts over 2.5 lakh registered homoeopathy practitioners, nearly 300 teaching institutions, and millions of patients relying on this system as either primary or complementary medicine. With the global homoeopathy market valued at over USD 8 to 10 billion, India is well-positioned to challenge Germany's historical dominance.

The AYUSH Premium Mark and NABL certification ensure the globally aligned manufacturing and testing standards of Indian products. This robust framework, combined with India's unmatched practitioner and patient diversity, strengthens the credibility and visibility of Indian brands in international markets.